Literature DB >> 22011310

EUCAST technical note on Amphotericin B.

C Lass-Flörl1, M C Arendrup, J-L Rodriguez-Tudela, M Cuenca-Estrella, P Donnelly, W Hope.   

Abstract

The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for amphotericin B for Candida spp. This Technical Note is based on the EUCAST amphotericin B rationale document (available on the EUCAST website: http://www.eucast.org). Species-specific breakpoints for C. albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropicalis are S: MIC ≤1 mg/L, R: MIC > 1 mg/L. There are insufficient data to set breakpoints for other species. The breakpoints are based upon pharmacokinetic data, epidemiological cut-ff values and clinical experience. Breakpoints will be reviewed regularly.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22011310     DOI： 10.1111/j.1469-0691.2011.03644.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  31 in total

1.  Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.

Authors:  H Dabernat; C Delmas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-27       Impact factor: 3.267

2.  The antimicrobial effects of propolis collected in different regions in the Basque Country (Northern Spain).

Authors:  Josep Serra Bonvehí; Arrate Lacalle Gutiérrez
Journal:  World J Microbiol Biotechnol       Date:  2011-11-08       Impact factor: 3.312

3.  A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis.

Authors:  N Allou; Y Charifou; P Augustin; T Galas; D Valance; L Corradi; O Martinet; D Vandroux; J Allyn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-03       Impact factor: 3.267

4.  Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Authors:  A Espinel-Ingroff; M Arendrup; E Cantón; S Cordoba; E Dannaoui; J García-Rodríguez; G M Gonzalez; N P Govender; E Martin-Mazuelos; M Lackner; C Lass-Flörl; M J Linares Sicilia; M A Rodriguez-Iglesias; T Pelaez; R K Shields; G Garcia-Effron; J Guinea; M Sanguinetti; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 5.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

6.  Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.

Authors:  K M T Astvad; H K Johansen; B L Røder; F S Rosenvinge; J D Knudsen; L Lemming; H C Schønheyder; R K Hare; L Kristensen; L Nielsen; J B Gertsen; E Dzajic; M Pedersen; C Østergård; B Olesen; T S Søndergaard; M C Arendrup
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

7.  Waterborne Infections in Reunion Island, 2010-2017.

Authors:  Nicolas Allou; Aurélien Soubeyrand; Nicolas Traversier; Romain Persichini; Caroline Brulliard; Dorothée Valance; Olivier Martinet; Sandrine Picot; Olivier Belmonte; Jérôme Allyn
Journal:  Am J Trop Med Hyg       Date:  2018-07-19       Impact factor: 2.345

Review 8.  How to optimize the evaluation and use of antibiotics in neonates.

Authors:  Evelyne Jacqz-Aigrain; Florentia Kaguelidou; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-09-01       Impact factor: 3.278

9.  Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.

Authors:  Jamel Eddouzi; Valérie Hofstetter; Marizeth Groenewald; Mohamed Manai; Dominique Sanglard
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

10.  Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.

Authors:  A Forastiero; V Garcia-Gil; O Rivero-Menendez; R Garcia-Rubio; M C Monteiro; A Alastruey-Izquierdo; R Jordan; I Agorio; E Mellado
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.